Alera Investment Advisors, LLC Bristol Myers Squibb CO Transaction History
Alera Investment Advisors, LLC
- $822 Million
- Q2 2024
A detailed history of Alera Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alera Investment Advisors, LLC holds 5,462 shares of BMY stock, worth $294,729. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,462
Previous 15,396
64.52%
Holding current value
$294,729
Previous $834,000
72.9%
% of portfolio
0.03%
Previous 0.11%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,407Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.56 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.93 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.03 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.19 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...